Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
908
-
Total 13F shares, excl. options
-
228M
-
Shares change
-
+4.09M
-
Total reported value, excl. options
-
$54.2B
-
Value change
-
+$1.05B
-
Put/Call ratio
-
0.46
-
Number of buys
-
371
-
Number of sells
-
-421
-
Price
-
$238.03
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2018
1,031 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2018.
Elevance Health, Inc. - Common Stock (ELV) has 908 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 228M shares
.
Largest 10 shareholders include BlackRock Inc. (23.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (18.6M shares), VANGUARD GROUP INC (18.2M shares), STATE STREET CORP (10.2M shares), FMR LLC (9.91M shares), BAILLIE GIFFORD & CO (4.81M shares), Viking Global Investors LP (4.45M shares), WELLINGTON MANAGEMENT GROUP LLP (4.31M shares), Invesco Ltd. (3.92M shares), and First Eagle Investment Management, LLC (3.04M shares).
This table shows the top 908 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.